Mazdutide Peptide

Dual GLP-1/glucagon receptor agonist peptide. Studied for incretin pathway co-activation and metabolic signaling research.

$90.00

Quick Facts

SKUACR-MAZDU
SequenceModified oxyntomodulin analog
Purity≥97%
Physical FormLyophilized Powder
StorageStore at -20°C.

What is Mazdutide?

Mazdutide (LY3305677/IBI362) is a dual GLP-1 receptor and glucagon receptor agonist based on an oxyntomodulin backbone with C18 fatty acid acylation for extended duration via albumin binding. Oxyntomodulin is a naturally occurring 37-amino acid peptide that activates both GLP-1R and GCGR endogenously. Mazdutide was engineered to optimize the dual agonism ratio and extend the pharmacokinetic profile for once-weekly administration. Published research has characterized its receptor selectivity and binding kinetics. For laboratory research use only.

Frequently Asked Questions

What is Mazdutide?

Mazdutide is a dual GLP-1/glucagon receptor agonist based on modified oxyntomodulin with C18 fatty acid acylation for weekly dosing. It combines GLP-1R and GCGR co-activation. For research use only.

For laboratory and research use only. Not intended for human or animal consumption. All product information is derived from published preclinical research and does not constitute medical advice or claims.